Procter & Gamble Hygiene and Health Care Limited

PGHH Shareholders Approve Srividya Srinivasan as Whole-time Director

Shareholders of Procter & Gamble Hygiene and Health Care Limited approved the appointment of Ms. Srividya Srinivasan as a Whole-time Director for five years. The approval was confirmed at the 62nd Annual General Meeting held on September 8, 2026.

PGHH 62nd AGM: All 6 Resolutions Passed Unanimously

PGHH's 62nd AGM on September 8, 2026, saw all six resolutions passed. Key decisions included adopting financial statements, declaring dividends, re-appointing Mr. Pramod Agarwal, and appointing Ms. Srividya Srinivasan as Whole-time Director. Voting results confirmed strong shareholder support across all resolutions.

PGHH Holds 62nd AGM: Approves Dividends, Reappoints Director, Appoints New Whole-time Director

PGHH held its 62nd AGM on September 8, 2026. The meeting approved financial statements, dividends, reappointed Pramod Agarwal, and appointed Srividya Srinivasan as Whole-time Director. FY26 saw flat sales and 19% PAT growth.

PGHH FY26 Results: Revenue at ₹4,290 Cr, PAT ₹857 Cr; Proposes ₹60 Final Dividend

Procter & Gamble Hygiene and Health Care Limited reported FY26 revenue of ₹4,290 crore and PAT of ₹857 crore, up 19%. The board recommended a final dividend of ₹60 per share. The 62nd AGM for FY26 is scheduled, with registration for speakers closing September 1, 2026. P&G Shiksha impacted over 1 crore children.

PGHH Files Business Responsibility & Sustainability Report for FY 2025-26

Procter & Gamble Hygiene and Health Care Limited has filed its Business Responsibility & Sustainability Report for FY 2025-26. The report covers the company's strategy, CSR initiatives like P&G Shiksha, and its commitment to diversity and inclusion. It details operations, products, and employee welfare measures, emphasizing adherence to ethical standards and sustainability.

PGHH Announces 62nd AGM, FY26 Revenue at ₹4,290 Cr, PAT ₹857 Cr

Procter & Gamble Hygiene and Health Care Limited reported FY26 revenue of ₹4,290 crore and Profit After Tax (PAT) of ₹857 crore, a 19% increase. The company announced its 62nd AGM and recommended a final dividend of ₹60 per share, totaling ₹255 for the year. Key product innovations include Whisper Nights and Vicks Cough Syrup.

PGHH Announces AGM on Sep 8, 2026; Record Date Sep 1

Procter & Gamble Hygiene and Health Care Limited will hold its 62nd Annual General Meeting (AGM) on September 8, 2026. The record date for the AGM and dividend payment is September 1, 2026. Approved dividends will be paid by October 6, 2026.

PGHH Revises AGM Date to Sep 8, Sets Record Date for Sep 1.

PGHH has revised its 62nd Annual General Meeting (AGM) to Tuesday, September 8, 2026. The Record Date for AGM and dividend payment is set for Tuesday, September 1, 2026. Dividend, if approved, will be paid by October 6, 2026.

PGHH Q1 FY27 Sales Down 5% to ₹901 Cr, PAT at ₹126 Cr Amidst Cost Pressures

PGHH reported Q1 FY27 sales of ₹901 Cr, down 5% YoY. PAT was ₹126 Cr, impacted by commodity costs. The company increased investments in innovation and advertising. Managing Director Kumar Venkatasubramanian remains confident in the Integrated Growth Strategy.

PGHH Q1FY27 Profit Declines 34% to ₹1262.7 Crore; Revenue Down 7%

Procter & Gamble Hygiene and Health Care Limited reported its Q1 FY27 results. Total income decreased to ₹891.46 crore from ₹937.03 crore YoY. Profit for the quarter fell 34% to ₹126.27 crore from ₹192.06 crore. EPS was ₹38.90.

PGHH Announces 62nd AGM on Sep 2, 2026; Record Date Aug 26

Procter & Gamble Hygiene and Health Care Limited has updated its 62nd Annual General Meeting (AGM) schedule. The AGM will take place on September 2, 2026. The record date for the AGM and dividend payment is August 26, 2026. Approved dividends will be paid by September 30, 2026.

PGHH Revises AGM Date to Sep 2, 2026; Sets Aug 26 Record Date

Procter & Gamble Hygiene and Health Care Limited has rescheduled its 62nd Annual General Meeting (AGM) to September 2, 2026. The record date for the AGM and dividend payment is set for August 26, 2026. Approved dividends will be disbursed by September 30, 2026.

PGHH Submits SEBI Compliance Certificate for Q1 FY27

PGHH submitted a certificate under SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended June 30, 2026. The certificate confirms the processing of dematerialised securities and updates to the register of members. The submission was made on July 10, 2026.

PGHH Appoints Gopalakrishnan Kalianna as Sales Head, Rohini Venkateswaran to Korea

PGHH appoints Gopalakrishnan Kalianna as Sales Head effective August 1, 2026. He succeeds Rohini Venkateswaran, who will move to Senior Vice President-Korea on the same date. Kalianna has over 20 years of experience at P&G.

PGHH Promoter Group Holds 86.01 Lakh Shares (51.82%) as of March 31, 2026

Procter & Gamble Overseas India B.V. and PACs hold 86,01,071 shares (51.82%) in Procter and Gamble Health Limited as of March 31, 2026. No encumbrance on these shares was reported for the financial year ended March 31, 2026.

PGHH Declares ₹60 Dividend for FY26; TDS Rules Updated

PGHH declared a final dividend of ₹60 per equity share for FY26, subject to AGM approval. The company updated shareholders on TDS regulations for dividend income as per the Income Tax Act, 2025. Shareholders must submit updated details and forms by August 14, 2026, to ensure correct TDS application.

Temple Trees Impex Transfers 1.91% Stake to PGHPPL; No Change in Control

Temple Trees Impex and Investment Pvt Ltd transferred its entire 1.91% stake (6,19,683 equity shares) in Procter & Gamble Hygiene and Health Care Limited to Procter & Gamble Home Products Private Limited on June 18, 2026. The transaction was an on-market trade and does not alter control or management.

PGHH Holds Investor Call: Sales Flat, PAT Up 19% FY26; Discusses Growth Strategy

PGHH reported FY26 sales of ₹4300 crore, flat year-on-year, but PAT grew 19% to ₹850 crore due to savings programs. The company detailed its integrated growth strategy focusing on product superiority, productivity, and innovation. Key product upgrades include Whisper Period Panties and Vicks ZzzQuil. Productivity savings of ₹86 crore were achieved.

PGHH Investor Presentation: FY26 Sales Flat, PAT Up 19%, Rs 86 Cr Productivity Savings

Procter & Gamble Hygiene and Health Care Limited's FY25-26 results show flat sales and a 19% rise in PAT. The company achieved ₹86 crore in productivity savings and aims for long-term growth. The presentation was shared on June 16, 2026.

PGHH Announces Senior Management Change: Mohit Pradhan to Lead Feminine Hygiene Business

PGHH appoints Mohit Pradhan as VP & Category Leader for Feminine Hygiene Business, effective August 1, 2026. He replaces Girish Kalyanaraman, who is moving to a new role within P&G effective July 1, 2026.

PGHH Schedules Virtual Investor Meet for June 16

PGHH will host a virtual meeting with analysts and institutional investors on June 16, 2026, at 1:30 p.m. IST. Registration is mandatory by June 7, 2026. No unpublished price-sensitive information will be discussed.

PGHH FY26 PAT up 19% to ₹857 Crore; Recommends ₹60 Final Dividend

Procter & Gamble Hygiene and Health Care Ltd. reported FY26 sales of ₹4290 crore (flat YoY) and PAT of ₹857 crore, up 19%. Q4 FY26 sales were ₹941 crore (-5% YoY) with PAT at ₹153 crore (-2% YoY). The company recommended a final dividend of ₹60 per share, making total dividend ₹255 per share.

PGHH Appoints Srividya Srinivasan as CFO; Hegde & Bhartia Resign

PGHH Board approved leadership changes on May 28, 2026. Ghanashyam Hegde resigns as Company Secretary/Compliance Officer (June 30, 2026) and becomes Non-Executive Director (July 1, 2026). Gaurav Bhartia resigns as CFO (June 30, 2026). Srividya Srinivasan appointed Executive Director & CFO from July 1, 2026.

PGHH: Key Management Changes: Ms. Srividya Srinivasan Appointed CFO, Effective July 1, 2026

PGHH announced key management changes effective July 1, 2026. Ms. Srividya Srinivasan appointed Executive Director and CFO. Mr. Ghanashyam Hegde re-designated as Non-Executive Director. Mr. Gaurav Bhartia resigns as CFO. Mr. Hegde also ceases as Company Secretary and Compliance Officer on June 30, 2026.

PGHH Announces Key Management Changes: New CFO Appointed, Directors Re-designated

PGHH announced changes in its leadership team. Ghanashyam Hegde ceases as Company Secretary on June 30, 2026, and becomes Non-Executive Director from July 1, 2026. Gaurav Bhartia resigns as CFO on June 30, 2026. Srividya Srinivasan appointed as new CFO and Executive Director from July 1, 2026.

PGHH Announces Key Management Changes: New CFO Appointed, Director Transitions

PGHH Board approved leadership changes effective July 1, 2026. Ms. Srividya Srinivasan appointed Executive Director & CFO. Mr. Ghanashyam Hegde re-designated Non-Executive Director. Mr. Gaurav Bhartia resigns as CFO. All changes effective July 1, 2026, except for Hegde's cessation as CS/Compliance Officer on June 30, 2026.

PGHH Recommends ₹60 Dividend; FY26 Audited Results Approved

Procter & Gamble Hygiene and Health Care Limited approved its audited financial results for FY26. The company recommended a dividend of ₹60 per equity share, payable by September 18, 2026, pending member approval at the AGM. The Board Meeting commenced at 12:43 pm and concluded at 13:34 pm on May 28, 2026.

PGHH Approves FY26 Audited Results, Recommends ₹60 Dividend

Procter & Gamble Hygiene and Health Care Limited approved audited financial results for FY26. The company recommended a dividend of ₹60 per equity share, payable by September 18, 2026. For FY26, profit after tax was ₹85,650 Lakhs and basic EPS was ₹263.86.

PGHH Announces Key Management Changes: New CFO Appointed, Directors Re-designated

PGHH announced changes in its leadership. Mr. Ghanashyam Hegde will be re-designated as Non-Executive Director from July 1, 2026, after ceasing as Company Secretary on June 30, 2026. Ms. Srividya Srinivasan is appointed as Executive Director and CFO from July 1, 2026, for a five-year term.

PGHH Sets August 17, 2026 as Record Date for 62nd AGM and Dividend

Procter & Gamble Hygiene and Health Care Limited has set August 17, 2026, as the record date for its 62nd Annual General Meeting (AGM) and dividend payment. The AGM is scheduled for August 24, 2026. This announcement was made on May 28, 2026.

PGHH Files SEBI Reg. 74(5) Certificate for Q4 FY26

Procter & Gamble Hygiene and Health Care Limited submitted its SEBI Regulation 74(5) certificate for the quarter ended March 31, 2026. The company confirmed the processing of dematerialised securities and the substitution of depositories in the register of members.

PGHH: SEBI Extends Special Window for Physical Share Transfer Requests

SEBI has extended the special window for re-lodging transfer requests of physical shares until February 4, 2027. This applies to transfer deeds lodged before April 01, 2019, that were rejected. All re-lodged securities will be processed in dematerialized form.

PGHH: Trading Window Closed from April 1 for FY26 Audited Financials

Procter & Gamble Hygiene and Health Care Limited will close its trading window for directors and designated employees from April 1, 2026. This closure will last until 48 hours after the publication of the audited financial statements for the quarter and financial year ending March 31, 2026.

Procter & Gamble Hygiene Appoints Robin Thadathil as Head of HR

Mr. Srinivas Maruthi Patnam is resigning as Head of HR for Procter & Gamble Hygiene and Health Care Limited, effective March 31, 2026. Mr. Robin Thadathil will succeed him, taking charge on April 1, 2026. Thadathil has over 16 years of HR experience within P&G.

PGHH Company Secretary Ghanashyam Hegde to move to regional role effective July 1, 2026

Ghanashyam Hegde, Legal Head, Executive Director, and Company Secretary of PGHH, will move to a regional role as Vice President & Associate General Counsel – Market Operations, India, Middle East, Turkey & Africa. This transition will be effective July 1, 2026.

PGHH: Legal Head Ghanashyam Hegde to Move to Regional Role Effective July 1, 2026

Mr. Ghanashyam Hegde, Legal Head, Executive Director, and Company Secretary of Procter & Gamble Hygiene and Health Care Limited, will move to a regional role. He will become Vice President & Associate General Counsel – Market Operations for India, Middle East, Turkey & Africa, effective July 1, 2026.

PGHH Legal Head Ghanashyam Hegde to move to regional P&G role July 1

Mr. Ghanashyam Hegde, Legal Head, Executive Director, and Company Secretary of Procter & Gamble Hygiene and Health Care Limited, will move to a regional role. Effective July 1, 2026, he will be Vice President & Associate General Counsel – Market Operations, India, Middle East, Turkey & Africa.

PGHH Declares ₹195 Interim Dividend, Including ₹25 Special Dividend

Procter & Gamble Hygiene and Health Care Limited declared an interim dividend of ₹195 per equity share for FY 2025-26, which includes a special dividend of ₹25. The record date for this dividend is February 5, 2026. The company has outlined TDS procedures for resident and non-resident shareholders.

PGHH declares interim dividend of ₹195/share, including ₹25 special dividend.

Procter & Gamble Hygiene and Health Care Limited declared an interim dividend of ₹195 per equity share for FY25-26, including a ₹25 special dividend. The dividend will be paid by February 27, 2026. The record date is February 5, 2026. The company also approved its unaudited financial results for the quarter ended December 31, 2025.

PGHH Declares Interim Dividend of ₹195/Share, Record Date Feb 5

Procter & Gamble Hygiene and Health Care Limited declared an interim dividend of ₹195 per equity share for FY25-26, including a special ₹25 dividend. The record date is February 5, 2026, with payment by February 27, 2026. Unaudited financial results for the quarter ended December 31, 2025, were also approved.

PGHH Declares Interim Dividend of ₹195/share, Including ₹25 Special Dividend

PGHH declared an interim dividend of ₹195 per equity share for FY25-26, including a special ₹25 dividend, payable by Feb 27, 2026. The record date is Feb 5, 2026. For Q3 FY26, PGHH reported a profit after tax of ₹30,146 Lakhs and revenue from operations of ₹126,190 Lakhs.

PGHH Files SEBI Regulation 74(5) Certificate for Q3 FY26

Procter & Gamble Hygiene and Health Care Limited submitted a certificate under SEBI Regulation 74(5) for the quarter ended December 31, 2025. The filing confirms the processing of dematerialised securities and updates to the register of members.

PGHH Closes Trading Window from Jan 1, 2026, for Q4 FY25 Results

Procter & Gamble Hygiene and Health Care Limited will close its trading window for Directors and designated employees from January 1, 2026. The window will reopen 48 hours after the announcement of the unaudited financial results for the quarter ending December 31, 2025.

Change in Senior Management Personnel at Procter & Gamble Hygiene and Health Care Limited

P&G Hygiene and Health Care announces Mr. Pawan Verma will cease to be Purchases Head, effective December 31, 2025, due to relocation. Mr. Kartik Harugoli will be appointed as Purchases Head effective January 1, 2026.

Change in Senior Management Personnel

Maithreyi Jagannathan resigns as Category Leader, Health Care, effective December 31, 2025. Tushar Gupta to take over the role effective January 1, 2026.

PGHH Announces Unaudited Financial Results for Quarter Ended Sep 30, 2025

PGHH reports ₹1150 crore in sales, a 1% YoY growth, and a PAT of ₹210 crore for the quarter ended September 30, 2025. The company focuses on integrated growth strategy and superior product portfolio.

PGHH Approves Unaudited Financial Results for Quarter Ended September 30, 2025

PGHH's Board approved unaudited financial results for the quarter ended September 30, 2025. Total income reached ₹1,160.07 lakh, with a profit before tax of ₹281.78 lakh and EPS of ₹64.65.

PGHH Announces Unaudited Financial Results for Quarter Ended September 30, 2025

PGHH's Board approved unaudited financial results for quarter ended September 30, 2025. Revenue from operations: ₹115,017 lakh, Net Profit: ₹20,986 lakh, EPS: ₹64.65.

Certificate under SEBI Regulations for Quarter Ended September 30, 2025

PGHH submitted a certificate under SEBI regulations confirming the dematerialization of securities for the quarter ended September 30, 2025.

Shareholders approve re-appointment of Mr. Chittranjan Dua as Independent Director for PGHH